Where PBMs fit into the new market access landscape, how pharma companies can respond and the questions that remain.
Steve Callahan
Advertisement
Steve Callahan is the senior director of Advisory & Insights at MMIT, managing several syndicated and episodic products, which synthesize actionable insights from a variety of healthcare decision-makers to inform key decisions and use cases. He holds an M.S. in biology from Fairfield University and an MBA from the University of Connecticut.
Articles by Steve Callahan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
3
What Unexpected Costs do GLP-1 Patients Face?
4
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
5